AKT1 and peripheral arterial disease: The main findings of the study were that WT in patients with PAD improved walking capacity, promoted angiogenesis, and increased the muscular expression of VEGF and miRNA-126, enhancing the PI3K/Akt/eNOS angiogenic pathway.